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The transcription factor STAT3 is a downstream target of the LIF signalling cascade. 
LIF signalling or activation is sufficient to maintain embryonic stem (ES) cells in an 
undifferentiated pluripotent state. To further investigate the importance of STAT3 in 
maintaining the pluripotency of ES cells we have generated transgenic FVB mice 
expressing a conditional tamoxifen dependent STAT3-MER fusion protein. 
Transgenic blastocysts have yielded pluripotent germ line competent ES cells at high 
frequency when established in a tamoxifen-containing medium in the absence of LIF. 
The expression profiling of tamoxifen induced transgenic FVB ES cell lines when 
compared with wild type cells has revealed a set of genes that were markedly up- or 
down-regulated. The expression of four of the up-regulated genes (Hexokinase II, 
Lefty2, Pramel7, PP1rs15B) was shown to be restricted to the inner cell mass (ICM) 
of blastocysts. These differentially expressed genes represent potential candidates 
for the maintenance of pluripotency of ES cells. We finally overexpressed two of the 
identified genes, Pem and Pramel7, in embryonic stem cells and demonstrated that 
their overexpression is sufficient for maintaining the expression of markers of the 
undifferentiated, pluripotent state and typical morphology of pluripotent ES cells in 




ES cell lines that keep their pluripotency after transfection and selection procedures 
are essential for the introduction of selected targeted mutations into the germ-line of 
mice. Pluripotent ES cells are established in vitro from the inner cell mass (ICM) cells 
of explanted blastocyst-stage embryos [1-3]. Murine ES cells are maintained in a 
pluripotent state by co-culturing with mitotically inactivated feeder cells, such as 
embryonic fibroblasts, and/or the addition of leukaemia inhibitory factor (LIF: [4, 5]. 
These ES cells can be maintained indefinitely in the presence of LIF, and express 
markers of the undifferentiated, pluripotent state, including the POU-domain 
transcription factor POU5F1 (OCT-4), a factor that is essential for the development of 
the ICM (reviewed by [6]; [7]. Upon removal of LIF, the cells rapidly lose self-renewal 
capacity and differentiate into a variety of cell types. The pathway by which LIF 
signalling acts to promote ES cell self-renewal has been well studied (reviewed by 
[8]. LIF belongs to the Interleukin-6 family of cytokines and the members of this 
family have diverse effects on a variety of cell types [9]. The shared usage of signal 
transducers (i.e. gp130) in the multichain cytokine receptor complexes clearly 
explains the functional redundancies of these cytokines (reviewed by [10].  
LIF signals via heterodimerization of the two class I cytokine receptors, the low 
affinity LIF receptor (LIFR) and the common subunit, gp130. The cytoplasmic domain 
of gp130 contains several tyrosinase residues that are phosphorylated by associated 
JAK (Janus kinase) kinases after ligand-stimulated dimerization. Four of these 
phosphorylated tyrosines have been identified as putative interaction sites with the 
SH2 (Src homology 2) domain of the transcription factor STAT3 (signal transducer 
and activator of transcription; [11]. Stimulation of gp130 signalling in ES cells also 
phosphorylates SHP-2 (SH2-domain-containing tyrosine phosphatase) and leads to 
activation of the mitogen-activated protein (MAP) kinases ERK1 and ERK2 [12]. 
Inhibition of the SHP-2/RAS/ERK pathway promotes self-renewal over differentiation 
and treatment of mouse ES cells with the MAPK-inhibitor PD098059 [13] was shown 
to enhance self-renewal [14].  
Matsuda et al. (1999) have shown that activation of the STAT3 transcription factor is 
sufficient to maintain an undifferentiated state of mouse ES cells in the absence of 
LIF [15]: A transgene-construct encoding an inducible fusion protein (STAT3-MER) 
was introduced into ES cells. The construct generated to express the fusion protein 
contains the entire coding region of STAT3 and the mutated ligand-binding domain of 
the estrogen receptor. The fusion protein is only active upon binding of the synthetic 
ligand 4-hydroxytamoxifen (OHT) but not endogenous estrogen. ES cells expressing 
the STAT3-MER fusion protein maintained their undifferentiated state in the presence 
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of OHT and in the absence of LIF [15]. If in vitro STAT3 activation is sufficient for 
stem cells maintenance, the in vivo relevance of the LIF pathway is not yet entirely 
clear. LIF expression can be detected in the TE of the blastocyst whereas LIF 
receptor is expressed in the ICM. However, neither LIF mutants [16] nor mutants of 
the receptors LIFR [17, 18] and gp130 [19] result in any defects in the development 
of the ICM or early epiblast. Recent evidence suggests that the LIF pathway is 
necessary for survival of the mouse epiblast during diapause [20]. 
Recent studies have begun to identify key players involved in the intracellular signal 
transduction pathways regulating stem cell renewal and proliferation. Several 
transcription factors including the POU5F1 have been shown to be essential to 
maintain pluripotency in ICM, but until recently none of them had been shown to 
function independently of the LIF pathway. The newly identified homeobox 
transcription factor Nanog, directs pluripotency in mouse ICM and mouse ES cells 
and functions independently from LIF dependent STAT3 activation [21, 22]. Nanog is 
detected in the ICM and early germ cells, as well as in the ES and embryonic 
carcinoma (EC) cell lines derived from these stages [21]. Overexpression of Nanog 
relieves mouse ES cells cultured without feeder cells in the presence of serum from 
dependence on LIF stimulation for self-renewal whereas nanog-deficient mouse ES 
cells loose pluripotency and differentiate into extra embryonic endoderm lineages 
[22]. 
ES cell lines exhibit different degrees of LIF dependency as has been demonstrated 
in STAT3 gene targeting experiments by Raz et al. [23]. ES cells heterozygous for a 
Stat3 mutation could only be established from E14 cells (129P2/OlaHsd; [24]. 
Targeted clones from other cell lines were invariably trisomic for chromosome 11 that 
carries the Stat3 locus, and retained normal levels of activated STAT3.  
In our study we have evaluated whether overexpression of active STAT3 supports 
the survival and derivation of pluripotent ES cells in the FVB/N mouse strain. To this 
extend we have generated FVB/N transgenic mice overexpressing a tamoxifen 
inducible STAT3. The inbred mouse strain FVB/N has been chosen since it is widely 
used for the generation of transgenic animals [25], however to this day only one 
germline competent ES cell line has been reported [26].  
Our data confirm that overexpression of STAT3 in the ICM of the blastocyst clearly 
supports establishment of ES cells in the FVB/N mouse strain. Furthermore, using 
germline proven ES cells we performed a microarray-analysis comparing WT and 
STAT3 overexpressing FVB/N ES cells and identified a pool of genes that are 
differentially expressed. In situ hybridization analysis of part of these genes showed 
expression in the central part of the morula and in the ICM of the blastocyst 
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suggesting a potential role of these candidate genes in maintenance of pluripotency. 
In order to confirm their potential role in maintaining pluripotency, two of the identified 
genes, Pem and Pramel7 were overexpressed in ES cells. We cultivated the ES cells 
in absence of LIF and observed that they maintained the typical morphology of 
pluripotent stem cells and expressed the characteristic pluripotency related markers 
SSEA-1 and Oct4. This clearly demonstrates that these two genes are involved in 
maintenance of pluripotency. 
 
Methods 
Generation, Identification, and Maintenance of Transgenic Mice 
The pCAGmusstat3ER plasmid containing the full length sequence of murine STAT3 
cDNA fused to the ligand-binding domain of mouse estrogen receptor under the 
control of the chicken β-actin promoter [15] was propagated in Escherichia coli 
DH5α and the minigene was excised with NotI. The fragments were purified from a 
1% agarose gel with a Qiaquick extraction kit (Qiagen, Basel, Switzerland) and 
processed as described. Nuclear injections into fertilized FVB/N oocytes were carried 
out by conventional methods [27, 28]. Transgenic founder were identified by PCR 
using the β-actin promoter specific primer ggbactfor2: (5’-GGG TTC GGC TTC TGG 
CGT G-3’) and a STAT3 specific primer mmSTAT3back2: (5’-CCA AGG TGC CAG 
GAA CTG CCG-3’). Two primers specific for the TAG-1 gene (TAG82B: 5’-ACA CGA 
AGT GAC GCC CAT CCG T-3’; TAG83F: 5’-GGA GGA GAG AGA CCC CGT GAA 
A-3’) were used as a positive control for both wild-type and transgenic mice.  
ggbactfor2 and mmSTAT3back2 generate a 397bp band whereas TAG82B and 
TAG83F generate a 300bp product. 
 
Cell culture 
ES Cell Medium for FVB/N ES cells: KSR-KDMEM (Invitrogen) with 1000 units per ml 
human LIF, KSR-KDMEM w/o LIF and KSR-KDMEM w/o LIF with 1 µM 4-
hydroxytamoxifen (OHT, Sigma).  
ES Cell Medium for E14 ES cells: G-MEM (Sigma) containing 100 mM sodium 
pyruvate (GIBCO), 10%FBS, 50 mM β-mercaptoethanol and containing 107 U/ml 
ESGRO murine LIF (Chemikon Int.). 
Embryonic feeder fibroblasts (MEF) were derived from explanted day 14 fetuses of 
CD-1-M-TKneo strain mice [29]. Prior to co-culturing with ES cells, confluent layers of 
MEF cells were treated with mitomycin C (10 µg/µl) for 2.5 hrs and extensively 




Embryo recovery, embryo culture, isolation of ES cell lines 
Donor females of strains FVB/N (RCC Füllinsdorf, Switzerland and Harlan Horst 
Postbus, Netherlands) were induced to ovulate by an injection i.p. of 5 I.U. PMSG 
(Folligon, Intervet), followed 46 h later by an i.p. injection of 5 I.U. HCG (Chorulon, 
Intervet). Subsequently, donor females were mated with STAT3-MER transgenic 
male mice. Morulae were flushed from the uterotubal junction 3 days after mating 
and cultured overnight in M16 medium (Sigma). Fully expanded blastocysts were 
transferred onto MEF in KSR-KDMEM, KSR-KDMEM w/o LIF with 1 µM OHT or 
KSR-KDMEM w/o LIF and cultured at 37°C in an atmosphere of 10 % CO2 in air for 
6-7 days without media changes. Full-grown ICMs were picked from the outgrown TE 
and transferred into droplets of trypsin-EDTA solution (Invitrogen) by a mouth-
controlled glass-capillary. The ICMs were dissociated mechanically into groups of 
cells and these aggregates reseeded onto embryonic feeder fibroblasts. 3-4 days 
later, compact stem cell colonies could be identified. Single colonies were 
dissociated as described above and reseeded. Subsequently, non-differentiating 
clonal lines were partly frozen, partly passaged onto 6 cm plates, and splitted after 2-
3 generations for further characterization. 
 
Karyotype and Sex Determination of ES cell lines 
For chromosome counts, ES cells were pre-treated for 3 hrs with colcemide (Sigma, 
0.05 µg/ml) and metaphase spreads were prepared according to Triman et al. 
(1975). Sex determination was carried out using primers specific for the smcy and 
smcx gene. The following primers were used: SMC4-1: 5’-CTG AAG CCT TTG GCT 
TTG AGC AAG CTA C-3‘; SMCX-1: 5’-CAA AGA ATT TGG CAG CGG TTT CCC T-
3‘. Female cell lines exhibit a single band of 341 bp whereas male cell lines exhibit 2 
bands of 341 and 312bp respectively. 
 
Generation of injection chimeras 
C57BL/6 host embryos were recovered at the morula stage from the oviducts of 
hormonally treated females and cultured overnight (see above). Blastocysts were 
transferred into drops of M16 medium (Sigma) and ES cells into drops of HEPES-
buffered ES-medium. About 10–15 ES-cells were injected into each blastocyst. After 
a recovery period of about 2 hrs, injected blastocysts were transferred into the 
uterine horns of pseudopregnant NMRI foster mothers (Harlan, England). Chimeric 
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offspring were identified by the absence of coat color pigmentation. Chimeric males 
were set up to breed at the age of about 8 weeks. 
 
Western Blotting 
ES cell cultures were homogenized with RIPA buffer (50 mM Tris-Cl pH 7.4, 1% NP-
40, 0.25% Sodium Deoxycholate, 150 mM NaCl). Protein concentration was 
determined with BCA-Method (Pierce). Samples were subjected to SDS–PAGE and 
blotted onto PVDF membranes (Millipore, Volketswil, Switzerland) at 100 V for 1–2 h 
at 4°C. Immunodetection and chemiluminescent visualization were performed as 
recommended by the supplier of the chemiluminescence blotting kit (Roche 
Diagnostics, Rotkreuz, Switzerland). Anti STAT3 antibody (C-20) was purchase from 
Santa Cruz Biotechnology, anti-phospho (Y705) was purchased from New England 
Biolabs. 
Immunohistochemistry and alkaline phosphatase staining 
For alkaline phosphatase staining the cells were washed with CMF-PBS and fixed in 
4% paraformaldehyde in PBS. The cells were washed with PBT (PBS with 0.1% 
triton X) and incubated in alkaline phosphatase buffer (100 mM Tris-Cl pH9.5, 50 mM 
MgCl2, 100 mM NaCl) containing the AP-substrates nitrotetrazolium-blue and X-
phosphate (Roche Diagnostics, Rotkreuz, Switzerland). 
For immunohistochemistry the cells were washed in PBS and fixed with 4% 
paraformaldehyde in PBS. Cells were washed with PBT and incubated with the 
primary antibodies diluted in PBT containing 2% (v/v) horse serum. Secondary 
fluorescence labelled antibodies were used for detection. Anti OCT-4 (N-19) 
antibodies were purchased by Santa Cruz Biotechnology, SSEA-1 (Mouse mAb) by 
Chemicon International and Alexa Fluor 488 anti mouse and Alexa Fluor 594 anti 
rabbit secondary antibodies were purchased by Molecular Probes. 
 
cRNA labelling and Hybridization of microarrays 
cDNA synthesis 1st round of amplification. RNA was combined with 1µg of T7-dT 
primer (5’-GGC CAG TGA ATT GTA ATA CGA CTC ACT ATA GGG AGG CGG-
(dT)24-3’) in a total volume of 12 µl and incubated at 70°C for 10 min. The reaction 
was placed on ice and the following reagents added in a total volume of 20 µl: first 
strand buffer (1x), DTT (10 mM), dNTP mix (500 µM), and Superscript III (200 units, 
Invitrogen) and incubated at 42°C for 2 h. Second strand synthesis was performed by 
adding the following reagents in a total volume of 150 µl: second strand buffer (1x), 
dNTP mix (200 µM), E. coli DNA ligase (10 units), E. coli DNA polymerase (40 units), 
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RNase H (2 units), and incubated at 16°C for 2 h. T4 DNA polymerase (10 units) was 
then added to fill in the ends of the cDNA and incubated at 16°C for an additional 15 
min. Following phenol:chloroform extraction and ethanol precipitation, the cDNA was 
resuspended in RNase-free water. Transcription was performed using Ambion’s 
(Austin, USA) MEGAscript reagents. A 20 µl reaction containing cDNA, NTP mix (7.5 
mM), reaction buffer (1x), and 2 µl enzyme mix was incubated at 37°C for 4 h and the 
primary cRNA was purified using the RNeasy kit (Qiagen, Chatsworth, CA) per the 
manufacturer’s specifications. Two hundred nanograms of the purified cRNA were 
then carried forward in the secondary amplification. Samples with less than 200 ng 
cRNA were concentrated to a 5 µl volume and the entire sample used for the next 
round of amplification. 
cDNA synthesis 2nd round of amplification. First-strand cDNA was synthesized by 
incubating the above cRNA with 1 µg of random primers (Invitrogen, Carlsbad, CA) 
at 70°C for 10 min. The reaction was then placed on ice and the following reagents 
added in a 20-µL reaction: first-strand buffer (1x), DTT (10 mM), dNTP mix (500 µM), 
and Superscript III (200 units). The reaction was incubated at 42°C for 2 h. RNase H 
(2 units) was added to the reaction and incubated at 37°C for 20 min and then heat-
inactivated. The cDNA was combined with 1 µg of the T7-dT primer and incubated at 
70°C for 10 min. The reaction was then placed on ice and the following reagents 
added for a final volume of 150 µl: second-strand buffer (1x), dNTP mix (200 µM), E. 
coli DNA Polymerase (40 units), and then incubated at 16°C for 2 h. T4 DNA 
polymerase (10 units) was added to fill in the ends of the cDNA and incubated at 
16°C for an additional 15 min. The cDNA was purified with phenol:chloroform and 
precipitated with ethanol.  
Biotin secondary IVT. The secondary transcription reaction was performed using the 
Enzo BioArray HighYield RNA kit (Affymetrix, Santa Clara, CA). The secondary 
cDNA was incubated at 37°C for 4 h in a 40 µl reaction as indicated by in the 
manufacturer recommendations and the labeled cRNA purified using the RNeasy kit. 
 
Array Hybridizations and Analysis 
The biotin-labeled cRNA was fragmented in 40 mM Tris-acetate buffer pH 8.1 
containing 100 mM potassium acetate and 30 mM Magnesium acetate. 15 µg of 
labelled cRNA was mixed with the appropriate buffers and hybridized to a mouse 
U74Av2 (Affymetrix) for 16 h at 45°C. Computer analysis of the resulting data was 
performed using the DChip software package [30]. Samples were run on triplicate 
microarrays and the resulting data combined into subsets and compared using 
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DChip. A total of 25 genes were identified as showing changes in gene expression 
using a value of 1.5 for the lower bound of the 95% confidence interval for the fold 
change as a cutoff. 
 
Real-Time Quantitative PCR (Q-PCR) 
The total RNA from cultured ES cells was obtained using Qiagen© Rneasy mini-kit 
and reverse transcribed with oligo-dT primers (Invitrogen) and SuperscriptIII 
(Invitrogen). Quantitative Real time experiments were performed with the 
SyberGreen technology using the Quantitec (Qiagen) and an ABI Prism 7700 cycler. 
For quantitation of gene expression comparative Ct-method was used after 
normalization with beta-actin. The following primers were used:  
βactin_fwd:  5’-cat cca ggc tgt gct gtc cct gta tgc-3’ 
βactin_bwd:  5’-gat ctt cat ggt gct agg agc cag agc-3’ 
Ebaf_fwd:  5’-aca gcg cgg atg tgg agg aga tgg-3’ 
Ebaf_bwd:  5’-atc ctc acg gac tct cag cca ttc a-3’ 
Eif2s2_fwd:   5’-tac atc gtc aac cca aac atc tcc ttg c-3’ 
Eif2s2_bwd:  5’-ggc acg gag ctg tgc tcg ctt-3’ 
Dppa3_fwd:  5’-agg gtc cgc act ttg ttg tcg gtg c-3’ 
Dppa3_bwd:  5’-gct cct aat tct tcc cga ttt tcg cat-3’ 
NDP5211_fwd: 5’-cat gag cag cta cag agg aag ca-3’ 
NDP5211_bwd: 5’-gtg cct cag att cac tgt gta gct aa-3’ 
pramel6_fwd:  5’-cag gaa gac gag tgg caa agc acg t-3’ 
pramel6_bwd:  5’-agc cct gga atc tca tag cct aca tc-3’ 
pramel7_fwd:  5’-gag gag aag cag aac atc agc aag a-3’ 
pramel7_bwd:  5’-ctc tta gag gcg tga cat cta ggt t-3’ 
stat3_fwd:  5’-ggc aag ggc ttc tcc ttc tg -3’ 
stat3_bwd  5’-agc tgc tgc ttg ttg gtg tat gg -3’ 
socs3_fwd:  5’-caa cat ctg ggc gca gcg cga gc-3’ 
socs3_bwd:  5’-cgc tgg tcc gag ctg tcg cgg ga-3’ 
Trim41_fwd:  5’-tga gcc gca tgt ttt gtc agg ctg c-3’ 
Trim41_bwd:  5’-c aca ctt cgc gct gga cta gga gct-3’ 
 
Quantitative RT-PCR for each gene was done in triplicates and the values were 
normalized to the corresponding amounts of β-actin RNAs. Each Ct value used for 
the calculation was the mean of results obtained from triplicates and PCR were 
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performed with an ABI Prism 7700 Sequence Detection System (Applied Biosystems, 
Rotkreuz, Switzerland). 
 
In situ hybridization 
Template for riboprobe synthesis were obtained by amplification through RT-PCR. 
Briefly, total RNA was isolated from FVB/STAT3-MER ES cells cultivated in presence 
of 4OHT and RT was performed with oligo-dT primers. 300-400bp long fragments 
containing part of the ORF of the genes of interest were amplified by PCR and 
cloned in a pCRII® TOPO® dual promoter vector (Invitrogen). DNA templates for 
riboprobe synthesis were digested with appropriate enzymes to provide fragments for 
either sense or antisense orientation of the PCR product respect to the vector. 
Labelled riboprobes were synthesized by SP6 or T7 RNA polymerases by 
incorporation of digoxygenin-labelled UTPs.  
The embryos were transferred in a micro pore insert (12µm) sitting in a well of a 4 
well plate and fixed with freshly prepared 4% PFA/PBS, washed twice in PBT and 
dehydrated once in 25%, 50%, 75% and twice in 100% methanol/PBT. The 
dehydration was followed by rehydration in the reverse order of the MeOH/PBT 
series 75%, 50%, 25% for 5min each. The embryos permeabilized in RIPA buffer and 
refixed in 4% PFA/0.2% glutaraldehyde. After prehybridisation in hybridisation 
solution for ≥2 hours at 70°C the embryos were incubated in hybridisation solution 
containing 1.6 µg/ml of the corresponding riboprobe. As a control for the specificity of 
the labeling, in each hybridization experiment control embryos were hybridized with 
an equal concentration of a sense probe transcribed from the same template as the 
antisense probe. After high and low stringency washes hybridized riboprobes were 
detected using an AP-coupled anti-digoxigenin antibodies (Roche Diagnostics, 
Rotkreuz, Switzerland) and the AP-substrate BM-Purple (Roche Diagnostics, 
Rotkreuz, Switzerland). The staining reaction was stopped by rinsing in 2mM 
EDTA/PBT. Embryos were subsequently post-fixed in 4% PFA/0.1% glutaraldehyde 
in PBT and cleared in a glycerol:PBT 1:1 solution. 
Overexpression of Pramel7, Pem and Nanog 
The full length open reading frames (ORF) of Pramel7 and Pem were amplified by 
RT-PCR and sequenced. The full length cDNAs were cloned in the pfloxedNanog 
expression vector [21] by exchanging the Nanog cDNA with either the one of Pem or 
Pramel7. The expression vectors were completely sequenced and finally 
electroporated in E14 ES cells. After selection with puromycin single colonies were 
isolated and expression levels were determined by real time PCR. The clones with 





Generation of transgenic mice overexpressing STAT3-MER 
We overexpressed a fusion protein composed of the entire coding region of mouse 
STAT3 and the modified ligand-binding domain (G525R) of mouse estrogen receptor 
[15]. The modified ligand-binding domain binds the synthetic steroid ligand 4-
hydroxytamoxifen (4OHT) but not 17β-estradiol [31]. The expression of the transgene 
is driven by a chicken β-actin promoter and therefore is expected to express 
ubiquitously. After injection of the construct into the pronucleus of fertilized FVB/N 
eggs we obtained seven positive founder animals. When crossed with wild-type 
FVB/N partners, six of them showed germ line transmission. Multiple tissue analysis 
was performed by western blot in order to define animals exhibiting ubiquitous 
expression (data not shown). Two lines (Tg741 and Tg743) expressing large 
amounts of STAT3-MER were selected for further experiments. Both transgenic lines 
contain a single integration of the transgenic cluster and were maintained in a 
hemizygous state by breeding with WT FVB/N mice. 
 
Overexpression of inducible active STAT3-MER enables the establishment of 
germline competent ES cells from FVB/N blastocysts 
We were able to establish both wild type and transgenic ES cell lines. However, wild-
type ES cells were only obtained when LIF was present in the medium (Table 1). 
When using OHT-supplemented Medium without LIF 50-73 % of the embryos from 
both Tg741 and Tg743 transgenic lines yielded ES cell lines, all of them being 
transgenic (Table 1). Because the mice used were hemizygous for the transgene it is 
fair to assume that we were able to derive ES cells from virtually all the transgenic 
embryos. These results strongly indicate a supportive effect of active STAT3 on the 
maintenance of pluripotent ES cells. In order to confirm the pluripotency of these ES 
cells karyotypically normal male cells from both transgenic lines (Tg741 and Tg743) 
have been injected into C57BL/6 host blastocysts. Chimeric males were identified by 
the absence of eye (pink) and coat (albino) pigmentation and mated to wildtype 
FVB/N females. Germline transmission of the FVB/N ES cell genome resulted in 
albino offspring. To confirm that overexpression of active STAT3 supports the 
survival and derivation of pluripotent ES cells also in the F1 generation, transgenic 
germline F1 offspring from the line Tg741 were mated to wildtype animals. Blastocyst 
stage embryos were isolated and cultivated as previously described, if cultivated in 
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presence of 4OHT stem cell lines could be established from 44% of the embryos, all 
lines being transgenic (Table1). 
 
Characterization of the newly established FVB/N ES cells overexpressing STAT3-
MER 
The expression level of STAT3-MER in the ES clones obtained from the line 743, 
was tested by western blot (see Fig. 1). Furthermore, upon LIF stimulation STAT3 is 
phosphorylated on the tyrosine residue (Y705), dimerizes and can bind DNA [32, 33]. 
In order to test if 4OHT is able to induce STAT3-MER phosphorylation FVB/N ES 
cells expressing STAT3-MER were stimulated either with LIF or 4OHT for 10 minutes 
up to 24 hours. Cell extracts were separated by SDS-PAGE, blotted and probed with 
anti-STAT3 and anti-phospho (Y705) antibodies (Fig. 1). LIF stimulation induced 
tyrosine phosphorylation of both endogenous STAT3 and STA3-MER. As previously 
observed [15], endogenous STAT3 was dephosphorylated rapidly whereas 
dephosphorylation kinetics of STAT3-MER were slower. A dose dependence could 
be also observed, in ES cells derived from the Tg743 line, that are expressing higher 
STAT3-MER amounts, dephosphorylation was slower compared to the cells derived 
from the lower expressing Tg747 line (data not shown). In Tg743 derived ES cells 
stimulation with 4OHT resulted in a strong tyrosine phosphorylation of STAT3-MER, 
only a limited phosphorylation could be detected for endogenous STAT3. During the 
24 hours of induction with either LIF or 4OHT expression of Oct4 was confirmed 
(data not shown). 
 
ES cells overexpressing STAT3-MER express the typical ES-cell markers 
ES cells, as well as cells of the ICM of mouse blastocysts, express a panel of surface 
markers that are used to characterize undifferentiated, pluripotent embryonic cells. 
The expression of the transcriptional factor OCT-4 and the surface marker SSEA-1 
was tested by immunohistochemistry; wild type as well as the transgenic ES cells 
expressed both markers (see Fig. 2). Nanog expression was tested by semi-
quantitative RT-PCR, also in this case the cells were expressing nanog but no 
expression differences between WT and STA3TER overexpressing cells could be 
detected (Fig. 1B). In all cases the expression was restricted to the ES cells and no 
signal could be detected in the inactivated fibroblast used as feeder cells. 
 
Microarray analysis 
In order to identify which genes are regulated trough overexpression of STAT3 we 
compare WT FVB cells cultivated in presence of LIF with transgenic FVB cells 
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overexpressing STAT3-MER cultivated in presence of 4OHT. Total RNA was isolated 
and an expression analysis was performed by hybridizing Affymetrix chips containing 
probes covering the complete mouse transcriptome. Genes showing expression 
changes higher then 1.5fold were considered. We first could confirm the 
overexpression of STAT3-MER beeing the ration of the transgenic line 743 40 times 
higher than the WT. We furthermore could identify a set of 25 genes differentially 
regulated, 11 were upregulated (Table 2) whereas 14 were downregulated (Table 3).  
 
In situ Hybridization 
Nine out of the 25 identified genes were considered as candidates to have a function 
in determination and maintenance of pluripotency in ES cells. With these genes in 
situ hybridization was performed in order to define in which regions of the 
preimplantation embryos these genes are expressed. The temporo-spatial 
expression was analyzed by whole mount in situ hybridisation of morulae and 
blastocysts. Four genes, Pramel7, Lefty2, Protein Phosphatase 1 regulatory subunit 
15B and hexokinase II were expressed only in the central part of the morula and in 
the ICM of the blastocyst (Fig 3). The other five genes, Pramel 6, Eif2s2, Pem, 
Dppa3 and Skp2 were found to be expressed in all cells of the morula and 
blastocysts (Fig 3A), a more exact analysis of the preimplantation stages was 
performed for the Pramel7 gene (Fig 3B).  
 
Overexpression of  Pem and Pramel7 allows cultivation w/o LIF 
For the overexpression the full length cDNAs of Pem and Pramel7 were inserted in 
the pfloxedNanog vector (see Chambers et al., 2003) instead of the cDNA of Nanog. 
The pfloxed vector was also electroporated in E14 cells as a positive control for the 
experiments. All electroporated cells were selected with puromycin and resistant 
colonies were picked and expanded. After testing for the presence of the vectors by 
PCR the positive clones were analyzed by real time PCR and the clones with the 
strongest expression were used for further experiments. In order to test for the 
capacity of maintaining pluripotency in absence of LIF, the cells were cultivated for 8 
days without addition of LIF to the medium. After 8 days in culture IHC was 
performed in order to detect the expression of OCT-4 and SSEA-1 (Fig.4). E14 WT 
ES cells started after 4 days to differentiate and showed the typical flattened 
morphology of differentiating cells (data not shown), after 8 days the cells were 
completely differentiated and didn’t express anymore OCT-4 and SSEA-1. Nanog 
overexpressing cells as expected maintained their pluripotent state also in absence 
of LIF. Both Pramel7 and Pem overexpressing clones showed a similar behaviour as 
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the Nanog overexpressing cells. The colonies maintained the typical round shaped 
morphology and expression of OCT-4 and SSEA-1 was present indicating that these 
two genes are able to maintain pluripotency also in absence of LIF. 
 
Discussion 
The data clearly support a necessary role for the gp130-JAK-STAT3 pathway in ES 
cell selfrenewal. Until to date the role of the STAT3 pathway in maintaining 
pluripotency in ES cell in vitro cultures was repeatedly demonstrated [15, 26]. Our 
work indicates that the activation of the STAT3 pathway during cultivation of 
blastocysts supports ICM outgrowth and clearly favors the establishment of new ES 
cell colonies in the FVB mouse strain. However, the in vivo relevance of the LIF 
pathway is not entirely clear. LIF is expressed in the TE of the blastocyst and the LIF 
receptor in the ICM, demonstrating the requirement of this pathway for pluripotent 
cell survival in vivo. However, neither LIF mutants [16] nor mutants of the receptors, 
LIFR [17, 18] and gp130 [19], cause any defects in the development of the ICM or 
early epiblast. Another key player in maintenance of pluripotency is the 
transcriptional factor OCT-4. The nature of the relationship between STAT3 and 
OCT-4 is not yet completely clear. OCT-4 has a fundamental role in maintaining 
pluripotency since ICM cells in OCT-4-deficient embryos are absent. The formation of 
a normal epiblast in STAT3-deficient embryos indicates that the function of STAT3 is 
dispensable and therefore, an interaction between OCT-4 and STAT3 is not 
obligatory in vivo [14]. Recent evidence suggests that the LIF pathway is necessary 
for survival of the mouse epiblast during implantation delay [20]: reviewed by [34], the 
so-called diapause. Diapause is a state of arrested development occurring in mated 
female mice that are lactating or have been experimentally ovariectomized. During 
diapause the embryos develop to the hatched blastocyst stage but do not implant 
until maternal estrogen is restored (reviewed by [35]. Normal embryos can resume 
development even after 3 to 4 weeks of implantational delay. In contrast, embryos 
lacking gp130 fail to recover after only a few days in diapause, due to an inability to 
maintain pluripotency of the epiblast. In addition, the efficiency of ES cell 
establishment is enhanced when using blastocysts in diapause [36, 37] further 
emphasizing that signaling through gp130 is essential for prolongation of the epiblast 
life span. Furthermore, the knockout studies in the gp130 pathway demonstrate that 
the normal transient phase of epiblast expansion in vivo does not rely on gp130 
signaling. Evidence has been presented for a gp130-independent mechanism of 
supporting at least limited expansion of mouse ES cells [38].  
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In order to identify genes, which might be related to the STAT3 pathway we 
compared gene expression changes in FVB/N embryonic cells overexpressing 
activated STAT3 and cultivated in presence of 4OHT and absence of LIF compared 
with WT FVB cells cultivated in presence of LIF. A group of about 25 genes showed 
significant differential expression. These genes can be divided in different categories 
according to their function: The first group contains regulatory members of the 
STAT3 pathway that are involved in the regulation of downstream events of the 
JAK/STAT cascade (like SOCS-3, protein phosphatase-1 regulatory subunit 15B and 
Eif2s2), the second group of genes is involved in pluripotency maintenance and cell 
viability, whereas the third group contains genes involved in the regulation of the 
metabolism in ES cells. 
In the first group we find SOCS-3; the members of suppressor of cytokine signalling 
(SOCS) family have been implicated in the negative regulation of several pathways, 
particularly the JAK/STAT pathway, and since this signalling pathway is responsible 
for their induction, they form part of a classical negative feedback circuit. At least 
three different modulating mechanisms have been demonstrated: through the SH2 
domain they bind to phosphotyrosine on the target protein, leading to inhibition of 
signal transduction by N-terminal inactivation of JAK, by blocking access to STAT to 
the receptor sites, or by SOCS box-targeting bound proteins to proteosomal 
degradation. The transcriptional upregulation of SOCS-3, a member of the 
suppressor of cytokine signalling family, confirms that the functional overexpression 
of STAT3-MER induces the activation of the classical LIF-dependent negative 
feedback mechanism (for a review see [39]). Previously Duval et al. (2000) showed 
that expression of SOCS-3, but not SOCS-1 and SOCS-2, was stimulated in ES cells 
in presence of LIF. The author further demonstrated that, uncontrolled 
overexpression of SOCS-3 leads to repression of LIF-dependent transcription and 
severely reduces cell viability. This suggests that the disturbance of a well balanced 
SOCS protein content has adverse effects on cell survival [40]. Because the FVB ES 
cells overexpressing STAT3-MER are viable and pluripotent it is to assume that the 
SOCS-3 upregulation observed in presence of 4OHT is a modulatory reaction due to 
the overproduction of STAT3 in these cells, through this compensatory mechanism 
the cells are able to maintain a properly activated LIF signalling cascade. It is to 
believe that the upregulation of SOCS-3 is a direct transcriptional activation mediated 
through STAT3 because the promoters of both mouse and rat SOCS-3 genes 
contain putative STAT1/STAT3 binding elements, which are necessary and sufficient 
for LIF-dependent activation of the SOCS-3 promoter activity in reporter assays [41, 
42]. Protein phosphatase 1 regulatory subunit 15B (PP1rs15B) is a constitutively 
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expressed inhibitory subunit of PP1, one of the major eukaryotic serine/threonine 
phosphatases. PP1rs15B dephosphorylates the α-subunit of eIF2 [43]. Under 
stressful conditions four different kinases phosphorylate eIF2α, which leads to a 
decrease of translational activity. PP1rs15B maintains basal low levels of eIF2α 
phosphorylation in unstressed cells and therefore inhibits the shut down of 
translational activity [43]. The microarray data confirm an upregulation of both 
PP1rs15B and eIF2s2 indicating that these proteins seem to be involved in the 
regulation of the STAT3 overexpression, whether these genes have a function in 
maintenance of pluripotency is still unclear. 
The second group of interesting genes contains molecules involved in pluripotency 
and cell viability. Interestingly no changes in the regulation of the classical marker for 
pluripotent ES cells could be detected. Alkaline phosphatase, OCT-4, SSEA-1, and 
Nanog were correctly expressed in both wildtype and transgenic ES cell lines (see 
Fig 2), but the overexpression of STAT3 didn’t induce any changes in the expression 
levels. Regarding the Nanog expression, our observations are in accordance with 
previous works describing that nanog can function independently of STAT3 and that 
nanog appears not to be a transcriptional target of gp130. Because, in the absence 
of gp130 stimulation, endogenous nanog expression is insufficient to sustain self-
renewal, it is to assume that ES cells are normally propagated by collaboration 
between cytokine-activated STAT3 and nanog. Furthermore, even if increased 
Nanog concentrations render the LIF-R/gp130 signalling dispensable, maximal self-
renewal can be obtained by combination of nanog overexpression and LIF 
stimulation [21].  
Within the identified differentially expressed genes, genes of mainly unknown 
function are found that were previously correlated with pluripotency [44] or with 
embryo viability in somatic nuclei derived cloned blastocysts [45]. Dppa3, NDP52l1, 
Pramel6, Pramel7 were identified as a set of OCT-4 related genes that are not 
correctly reactivated in somatic nuclei derived cloned embryos. Mice lacking OCT-4 
gene develop to the blastocyst stage but die after implantation, due to the lack of 
truly pluripotent ES cells. Similarly, cloned animals deriving from transfer of somatic 
nuclei into enucleated oocytes mainly die after implantation of the embryo. Bortvin et 
al. examined the hypothesis that the limited developmental potency of cloned 
embryos is a result of incomplete reactivation of genes that, like OCT-4 function 
specifically in pluripotent embryonic cells. To test this hypothesis the authors 
identified 10 candidate genes with an expression pattern similar to Oct4 and 
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compared their expression between normal and cloned preimplantation embryos 
[45].  
Dppa3 (developmental pluripotency-associated 3; Stella; PGC7; Crg1) is 
preferentially expressed in primordial germ cells, oocytes and preimplantation 
embryos. In blastocysts, Dppa3 is expressed in TE and ICM and in the early 
postimplantation embryos Dppa3 expression disappears. The expression re-emerges 
when at day E7.5 the first primordial germ cells (PGCs) are built [46]. Dppa3 
knockout mice are compromised in development; some embryos develop to the two 
or four cell stage, but fail to reach 8-cell stage [45, 47]. Dppa3 was proposed by Sato 
et al. to play a role in germ line specification in mice by preventing nascent germ cell 
populations from a somatic cell fate and by retaining their pluripotency [46].Pramel6 
and Pramel7 (preferentially expressed antigen in melanoma like 6 and 7) are 
prevalently expressed in preimplantation embryos and embryonic pluripotent cells 
[45]. Our results confirm these expression patterns and clearly show that whereas 
Pramel6 is typically expressed in all cells of the morula and the blastocyst, Pramel7 
is expressed in the inner part of the morula and in the ICM of the blastocyst. The 
function of Pramel’s in embryonic development is unknown, but interestingly, PRAME 
inhibits retinoic-acid induced differentiation in mouse embryonic carcinoma F9 cells 
[48]. Recently Kaji et al (2006) showed that Pramel6 and Pramel7 expression is 
mediated by Mbd3, a component of the nucleosome remodelling and histone 
deacetylation (NuRD) complex [49]. Mbd3 knockout ES cells do not appropriately 
repress transcription of Pramel6 and Pramel7, which are normally expressed in 
preimplantation embryos [45]. Kaji et al. proposed that the Mbd3/NuRD-mediated 
silencing of Pramel6 and Pramel7 in ES cells offers an epigenetic environment in 
which Mbd3/NuRD is not absolutely required but facilitates differentiation. 
Furthermore the authors describe that Mbd3 deficiency leads to down regulation of 
Dppa3 in ES cells. In general, expression pattern analysis corroborates the idea that 
Dppa3, Pramel6 and Pramel7 are collaborating in deciding the fate of ES cells.  
Overexpression of Pramel7 in ES cells, allows the maintenance of pluripotency, as 
shown by IHC with the typical pluripotency related markers OCT-4 and SSEA-1, 
indicating the importance of this protein in maintaining ES cells in a pluripotent state 
(Fig. 4). 
Murine Pem is an X-linked homeobox-containing gene [50, 44], whose homeodomain 
shares important structural features with two other homeobox genes which are 
expressed in extra embryonic lineages and during spermatogenesis [51, 52]. The 
Pem protein is expressed in the late morula stage, in TE and ICM of blastocyst and 
after implantation in extra embryonic tissues, in the parietal and visceral endoderm, 
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but not in the primitive ectoderm derivatives. Pem is also expressed in ES cells, in 
primordial germ cells and in teratocarcinoma cell lines [53]. Fan et al. (1999) altered 
pem gene expression in ES cells for functional studies. Overexpression of Pem had 
no phenotype in ES cells, but blocked completely differentiation into the three primary 
cell lineages, when ES cells were cultured as embryoid bodies in suspension without 
LIF [54]. Two different models of action for Pem are possible. Fan et al. (1999) 
suggested that Pem first helps to maintain the undifferentiated cell state, and in a 
second step promotes a defined cell population of undifferentiated stem cells for 
differentiation into extra embryonic lineages [54]. Sasaki et al (1991) proposed an 
alternative in which Pem directs early differentiation to specific lineages, but does 
maintain actively the undifferentiated state [44]. 
NDP52l1 (Nuclear dot protein 52) was also identified from Bortvin et al. (2003) as a 
gene incorrectly reactivated after somatic cloning. The embryonic function is to date 
unclear but it is capable of forming dimers and contains contains leucine zipper 
motifs indicating a possible function in splicing processes. The last 50 aminoacids 
show strong homology to oocyte and gastrula zinc finger proteins, and especially to 
proteins containing a LIM domain [55]. The overexpression experiments confirm the 
previous observation indicating that the overexpression of Pem in ES cells allows the 
maintenance of pluripotency in absence of LIF (Fig. 4): 
The observed overexpression of hexokinase II corroborates the importance of this 
isoform of hexokinase in embryo viability. Upon fertilization and over the next 4 to 5 
days, the embryo undergoes significant changes in carbohydrate and amino acid 
consumption and utilization. The significance of enzyme isoforms and their relative 
changes in abundance in terms of embryo physiology and metabolism has not been 
fully determined, although it is evident that the isoforms of key enzymes do change 
during the pre- and periimplantation period. In all probability, glucose utilization 
during the preimplantation period is not regulated by transport across the plasma 
membrane or the absence of sufficient enzyme activity. Rather substrate availability 
(concentration) and the specific regulation of enzyme activity appear to control 
glucose utilization by the preimplantation embryo. Kinetic analysis of hexokinase in 
preimplantation mouse embryos indicates that there is a switch from isozyme I at the 
zygote to isozyme II at the blastocyst stage [56, 57]. Moreover, mice homozygous for 
hexokinase II deficiency die at approximately 7.5 days post-fertilization, indicating 
that hexokinase II is vital for mouse embryogenesis after implantation and before 
organogenesis [58]. Our observation that the concentration of hexokinase II is 
increased in cells overexpressing STAT3 confirms the importance of this isozyme for 
embryo viability and indicates that a correct energetic balance is extremely important 
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in the late stages of preimplantation and at the beginning of postimplantation in the 
embryos. 
In summary the data presented indicates that overexpression of functional 
STAT3MER in FVB/N blastocysts sustains the establishment of germline competent 
ES cells in absence of LIF. Furthermore, gene expression analysis of these 
transgenic cells cultivated in presence of OHT showed that 25 genes were 
differentially expressed compared to WT cells cultivated in presence of LIF. By in situ 
hybridization analysis it was possible to identify four up-regulated genes (Hexokinase 
II, Lefty2, Pramel7, PP1rs15B) which expression was restricted to the ICM of the 
blastocysts. These genes represent potential candidates for maintenance of 
pluripotency of ES cells. Overexpression of two of the upregulated genes, Pem and 
Pramel7, in E14 cells and cultivation in absence of LIF demonstrated that these two 
genes are able to maintain the embryonic stem cells in a pluripotent state without 
addition of LIF to the culturing media. WT cells cultivate under the same conditions 
differentiated and lost expression of the pluripotency markers OCT-4 and SSEA-1. 
All together these data show that overexpression of STAT3-MER facilitates the 
establishment of germline competent embryonic stem cells by activating genes 
directly involved in maintenance of pluripotency and opens the possibility to establish 
germline competent ES cells from non-permissive mouse strains. 
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Table 1: Establishment of FVB/N ES cells.  
WT FVB/N or hemizygous FVB/N males carrying the STAT3MER transgene (lines 
741 and 743) were mated with WT FVB/N females. Blastocysts were collected and 
cultivated either in presence of LIF or OHT. Outgrown ICM’s were picked and 
cultivated till ES cell colonies were visible. Cells were tested for the presence of the 
transgene by PCR analysis. As expected it was possible to establish WT ES cells 
only in presence of LIF but not when OHT alone was added to the culture. 
Furthermore in presence of OHT all both transgenic lines 741 and 743 generated ES 
cell colonies that were carrying the transgene. Because theoretically only 50% of the 
blastocysts were expected to be transgene it is to assume that the establishment 
frequency was almost 100%. After generation of germline competent chimera with 
the newly established 743 cell line hemizygous transgenic F1 animals were 
generated and mated with WT FVB/N females. In this breeding the establishment 
efficiency in presence of OHT was similar to one observed in the parental blastocysts 
indicating that the STAT3 induced stabilization is kept also in the F1 generation. 
 
Table 2: Upregulated genes. 
Genes upregulated after STAT3MER activation through OHT. 11 genes were found 
to be significantly upregulated when compared with WT FVB/N cells cultivated in 
presence of LIF. Only genes with a 1.5x fold increase were considered as significant. 
The expression levels of selected genes were confirmed by real time PCR analysis.  
 
Table 3: Downregulated genes.  
Genes downregulated after STAT3MER activation through OHT. 14 genes were 
found to be significantly downregulated when compared with WT FVB/N cells 
cultivated in presence of LIF. Only genes with a 1.5x fold decrease were considered 
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as significant. The expression levels of selected genes were confirmed by real time 
PCR analysis. 
 
Figure 1: Characterization of the 743 transgenic ES cell line:  
A. Phosphorylation/dephosphorylation analysis of Tyr705 in endogenous and 
transgenic STAT3. After 24 hours of LIF and OHT deprivation cells were cultivated in 
presence of either LIF or OHT. No changes in the protein expression levels could be 
detected, but after 24 hrs the Tyr705 residue of both transgenic and WT STAT3 was 
completely dephosphorylated. 10 minutes after addition of LIF the tyr705 residue of 
both STAT3 wasphosphorylated whereas after addition of OHT complete 
phosphorylation was obtained only after 6 hrs. B. Dephosphorylation of Tyr705 was 
analyzed by eliminating LIF or OHT from respectively WT or 743 cells. After 24 hrs 
dephosphorylation of WT Tyr705 was almost complete whereas the 
dephosphorylation of STAT3MER occurred only after 46 hrs. C. Nanog expression 
was tested by semi quantitative RT-PCR. Both WT and 743 ES cell lines expressed 
Nanog but no difference in expression levels could be detected. D. After injection of 
743 in C57BL/6 host blastocysts a 50-60% chimera was generated. Littermates from 
the crossing of the chimera with a WT FVB/N female generated white littermates, 
50% of which were hemizygous for the transgene, indicating germline competence of 
the 743 cell line. 
 
Figure 2: Immunohistochemical analysis of WT, 741 and 743 ES cell lines. All cell 
lines express the nuclear marker OCT-4, the surface marker SSEA-1 and alkaline 
phosphatase. The expression was restricted to ES cells. Mouse feeder cells were 






In situ hybridization of selected genes: A. Dppa3, Eif2s2, Pem and Pramel 6 
exhibited a general expression in all cells of the morula and of the blastocyst. 
Expression of Hexokinase II, Lefty-2 and PP1s15B was restricted to the cells of the 
inner part of the morula and to the ICM in the blastocyst. Sense probes in the same 
concentration of the antisense probes were used as negative controls for the 
hybridization. B. In situ hybridization with a Pramel 7 antisense riboprobe of 
preimplantation embryos; bottom right negative control with sense riboprobe. 
 
Figure 4:  
Immunohistochemical analysis of WT E14 ES cells and E14 overexpressing, Nanog, 
Pem and Pramel7: IHC analysis with OCT-4 and SSEA-1 was performed after 
cultivation of the cells for 8 days without LIF. E14 ES cells differentiated under these 
conditions and lost the expression of OCT-4 and SSEA-1. Both Pem and Pramel7 
overexpressing cells maintained their pluripotency. Nanog overexpressing cells, used 






































































15 LIF   8 5 5 - WT 
15 OHT   4 0 - - 
741 28 OHT 23 10 (43 %)*   7 7 (100 %)# 
743 28 OHT 14 10 (71 %)* 10 10 (100 %)# 
741-F1 26 OHT 18   8 (44 %)*   8   8 (100 %)# 
* percent colonies per picked ICM 
#
 percent transgenic per cell lines 
Figure 5
Table 2 
probe set Identifier Acc. 
Number 










AI848479 13 1.87 1.91  
94375_at hexokinase 2 Y11666 6 1.6 1.61 1.83 
95545_at IGF-1A: insulin-like 
growth factor 1A 
X04480 10 2.34 1.6  
98059_s_at lamin A: D49733 3 1.58 1.47  
95562_at NDP52l1 AA615127 11 2.66 2.08 2.59 
101368_at Pem :placentae and 
embryos oncofetal 
gene 
M32484 X 1.68 1.82  
103470_at Pramel6 AI596993 2 6.18 4.14 6.86 
93245_at Pramel7 AI645718 2 3.51 2.77 2.36 




AA869927 1 1.6 1.5  
162206_f_at SOCS-3: cytokine 
inducible SH2-
containing protein 3 
AV374868 11 4.56 4.4 4.13 














associated protein 1 (Crg1) 
AI606389 6 -2.16 -2.28 -3.56  
133948_at Eif2c4: Eukaryotic translation 
initiation factor 2C, 4 
AI504948 17 -1.53 -1.46  
134566_at Lefty2/ Ebaf: endometrial bleeding 
associated factor 
AI643778 1 -4.37 -3.66 -6.11 
103389_at lysine oxoglutarate reductase,  
saccharopine dehydrogenase 
AJ224761 6 -2.04 -1.71  
167617_r_at Mitsugumin 23, similar to 
[Oryctolagus cuniculus] 
AV224168 19 -1.89 -1.73  
166131_at NPC derived proline rich protein 1 AA561632 1 -1.55 -1.46  
138014_at Nucleoporin 153  AI846692 13 -1.55 -1.49  
168078_f_at phospholipase A2, group IB, 
pancreas 
AV073802 5 -2.24 -2.18  
167824_f_at Skp2: S-phase kinase-associated 
protein 2 (p45) 
AV299777 15 -1.74 -1.62 -1.73 
100499_at syntaxin 3 D29797 19 -2.09 -2.03  
166600_at T-STAR/ etoile/ SML-2 AA189288 15 -1.66 -1.52  
93568_i_at 
93569_f_at 
unknown, embryonic gene AI853444 14 -3.29 -2.94  
161004_at unknown EST AA250414  -2.06 -1.85  
167843_f_at unknown EST AV321065 14 -2.71 -1.81  
 
Figure 7
